EC Number | Crystallization (Comment) | Organism |
---|---|---|
3.4.11.18 | in complex with inhibitor N-2-[(3,5-difluorophenyl)acetyl]-N-[(3S,7R)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide | Escherichia coli |
3.4.11.18 | molecular docking of inhibitor N-2-[(3,5-difluorophenyl)acetyl]-N-[(3S,7R)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide and comparison with docking in Escherichia coli structure | Staphylococcus aureus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.11.18 | N-2-[(3,5-difluorophenyl)acetyl]-N-[(3S,7R)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide | - |
Escherichia coli | |
3.4.11.18 | N-2-[(3,5-difluorophenyl)acetyl]-N-[(3S,7R)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide | - |
Haemophilus influenzae | |
3.4.11.18 | N-2-[(3,5-difluorophenyl)acetyl]-N-[(3S,7R)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide | - |
Staphylococcus aureus | |
3.4.11.18 | N-2-[(3,5-difluorophenyl)acetyl]-N-[(3S,7R)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide | - |
Streptococcus pneumoniae |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.11.18 | Escherichia coli | P0AE18 | - |
- |
3.4.11.18 | Haemophilus influenzae | - |
- |
- |
3.4.11.18 | Staphylococcus aureus | - |
- |
- |
3.4.11.18 | Streptococcus pneumoniae | - |
- |
- |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.11.18 | MAP | - |
Staphylococcus aureus |
3.4.11.18 | MAP | - |
Haemophilus influenzae |
3.4.11.18 | MAP | - |
Streptococcus pneumoniae |
3.4.11.18 | MAP | - |
Escherichia coli |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.4.11.18 | 0.03 | - |
pH not specified in the publication, temperature not specified in the publication | Escherichia coli | N-2-[(3,5-difluorophenyl)acetyl]-N-[(3S,7R)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide | |
3.4.11.18 | 0.046 | - |
pH not specified in the publication, temperature not specified in the publication | Streptococcus pneumoniae | N-2-[(3,5-difluorophenyl)acetyl]-N-[(3S,7R)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide | |
3.4.11.18 | 0.06 | - |
pH not specified in the publication, temperature not specified in the publication | Haemophilus influenzae | N-2-[(3,5-difluorophenyl)acetyl]-N-[(3S,7R)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide | |
3.4.11.18 | 0.2 | - |
value above 0.2 mM, pH not specified in the publication, temperature not specified in the publication | Staphylococcus aureus | N-2-[(3,5-difluorophenyl)acetyl]-N-[(3S,7R)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide |